Home

Sun Pharmaceuticals Industries Ltd PE Ratio

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

PE

34.5

Last updated on: Feb 12, 2025

Key Highlights

  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd is 34.5 as of 12 Feb 15:30 PM .
  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Latest Trading Price of Sun Pharmaceuticals Industries Ltd is ₹ 1693 as of 12 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Sun Pharmaceuticals Industries Ltd

No data available

Company Fundamentals for Sun Pharmaceuticals Industries Ltd

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

Share Price

₹ 1693.65

-6.10 (-0.36%)

stock direction

Last updated on: Feb 12, 2025

Market Price of Sun Pharmaceuticals Industries Ltd

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Feb 20251693.65
11 Feb 20251699.75
10 Feb 20251732.55
07 Feb 20251749.5
06 Feb 20251742.5
05 Feb 20251753.4
04 Feb 20251767.05
03 Feb 20251739.95
01 Feb 20251742.7
31 Jan 20251743.1

SWOT Analysis Of Sun Pharmaceuticals Industries Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sun Pharmaceuticals Industries Ltd406363
Divis Laboratories Ltd158396
Cipla Ltd117088
Torrent Pharmaceuticals Ltd103663
Dr Reddys Laboratories Ltd101458
Mankind Pharma Ltd99897

PE Ratio of Sun Pharmaceuticals Industries Ltd Explained

406363

Market cap

11433

Earnings

34.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sun Pharmaceuticals Industries Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in %

About Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Sun Pharmaceuticals Industries Ltd News Hub

Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting a

Read more

20 Aug 24

Sun Pharmaceutical to invest USD 15 mn in Pharmazz Inc.

Sun Pharmaceutical Industries has entered into an agreement with Pharmazz Inc. Delaware US, pursuant

Read more

14 Aug 24

Sun Pharma Q1 PAT climbs 40% YoY to Rs 2,835 cr

Profit before tax was at Rs 3,423.5 crore in Q1 FY25, registering a growth of 37.98% on YoY basis. D

Read more

01 Aug 24

Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter

Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended Ju

Read more

01 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sun Pharmaceuticals Industries Ltd

What is the current PE Ratio of Sun Pharmaceuticals Industries Ltd?

The Current PE Ratio of Sun Pharmaceuticals Industries Ltd is 34.45 as on 12 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Feb 2025.

What was the PE Ratio of Sun Pharmaceuticals Industries Ltd last year?

The PE Ratio of Sun Pharmaceuticals Industries Ltd was 27.83 last year, now the PE ratio is 34.45, showing a year-on-year growth of 23.8%.

What does the PE Ratio of Sun Pharmaceuticals Industries Ltd indicate about its stock?

The PE Ratio of Sun Pharmaceuticals Industries Ltd is 34.45. This ratio indicates that investors are willing to pay 34.45 times the earnings per share for each share of Sun Pharmaceuticals Industries Ltd.

What is the PE Ratio Growth of Sun Pharmaceuticals Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sun Pharmaceuticals Industries Ltd grew by 23.8% whereas, the EPS ratio grew by -4.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions